About Sekkei Bio
Sekkei Bio is a company based in Chennai (India) founded in 2017 by Monalisa Chatterji.. Sekkei Bio has raised $2 million across 4 funding rounds from investors including Gates Foundation, Tenshi Life Sciences and BIRAC. Sekkei Bio offers products and services including In Silico Design Platform, Circular RNA Technology, and Formulation Services. Sekkei Bio operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Chimerix, Sana Biotechnology and Semma Therapeutics, among others.
- Headquarter Chennai, India
- Founders Monalisa Chatterji
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sekkei Bio Private Limited
- Date of Incorporation 28 Nov, 2017
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$13.69 K (USD)-16.67as on Mar 31, 2020
-
Net Profit
$-46.31 K (USD)-126.25as on Mar 31, 2020
-
EBITDA
$-59.68 K (USD)-63as on Mar 31, 2020
-
Total Equity Funding
$2 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Gates Foundation
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sekkei Bio
Sekkei Bio offers a comprehensive portfolio of products and services, including In Silico Design Platform, Circular RNA Technology, and Formulation Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-based platform for designing novel drug candidates for complex diseases
Evolves RNA for next-generation vaccines and therapeutic applications
Delivers peptides and RNA via nanoparticles for oral administration
Funding Insights of Sekkei Bio
Sekkei Bio has successfully raised a total of $2M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(01 Jun 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Grant - Sekkei Bio | Valuation |
investors |
|
| Jun, 2021 | Amount | Series A - Sekkei Bio | Valuation |
investors |
|
| Feb, 2021 | Amount | Seed - Sekkei Bio | Valuation | Tenshi Life Sciences |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sekkei Bio
Sekkei Bio has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gates Foundation, Tenshi Life Sciences and BIRAC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Delivers advanced finished dosage pharmaceuticals using global infrastructure and quality systems.
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location | |
|
Business incubation services are provided across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sekkei Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sekkei Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sekkei Bio Comparisons
Competitors of Sekkei Bio
Sekkei Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Chimerix, Sana Biotechnology and Semma Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Sekkei Bio
When was Sekkei Bio founded?
Sekkei Bio was founded in 2017.
Where is Sekkei Bio located?
Sekkei Bio is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Is Sekkei Bio a funded company?
Sekkei Bio is a funded company, having raised a total of $2M across 4 funding rounds to date.
What is the annual revenue of Sekkei Bio?
Annual revenue of Sekkei Bio is $13.69K as on Mar 31, 2020.
What does Sekkei Bio do?
Sekkei Bio was founded in 2017 in Chennai, India, within the biotechnology sector. In-silico and mRNA technology platforms are utilized to create vaccines and small-molecule drugs. These efforts target diabetes, infectious diseases, and cancer. Operations focus on research and development for therapeutic solutions, with a base in the Indian pharmaceutical landscape.
Who are the top competitors of Sekkei Bio?
Sekkei Bio's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
What products or services does Sekkei Bio offer?
Sekkei Bio offers In Silico Design Platform, Circular RNA Technology, and Formulation Services.
Who are Sekkei Bio's investors?
Sekkei Bio has 3 investors. Key investors include Gates Foundation, Tenshi Life Sciences, and BIRAC.